Gene: TMEM11
Official Full Name: transmembrane protein 11provided by HGNC
Gene Summary: Involved in mitochondrion organization. Located in mitochondrial inner membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33801 | TMEM11 Knockout cell line (HeLa) | Human | TMEM11 | 1:3~1:6 | Negative | Online Inquiry |
KO33802 | TMEM11 Knockout cell line (HCT 116) | Human | TMEM11 | 1:2~1:4 | Negative | Online Inquiry |
KO33803 | TMEM11 Knockout cell line (HEK293) | Human | TMEM11 | 1:3~1:6 | Negative | Online Inquiry |
TMEM11 Gene Knockout Cell Lines are a specialized collection of genetically modified cells that have had the TMEM11 gene inactivated, allowing researchers to investigate the role of this gene in cellular processes. TMEM11 encodes a transmembrane protein thought to be implicated in several critical biological functions, including endosomal trafficking and immune responses. By utilizing these knockout cell lines, scientists can study the resultant phenotypic changes and gain insight into the molecular mechanisms driven by the TMEM11 protein.
The key function of these cell lines lies in their ability to facilitate the study of gene function and signaling pathways associated with the TMEM11 gene. The knockout model provides a platform for analyzing alterations in cellular behavior, gene expression, and protein interactions, which can yield critical information regarding its role in physiological and pathological contexts. This is particularly relevant in areas such as cancer research, where altered trafficking and immune evasion can significantly influence tumor progression.
The scientific importance of TMEM11 Gene Knockout Cell Lines is underscored by their application in both research and clinical settings. They serve as invaluable tools for drug discovery, helping to identify potential therapeutic targets, and can also provide insights into the genetic basis of certain diseases, ultimately aiding in the development of precision medicine strategies.
What sets our TMEM11 Gene Knockout Cell Lines apart from alternatives is the rigor with which they have been produced and validated. Each line undergoes extensive characterization to confirm successful gene editing, ensuring reliability in experimental results. Moreover, they are developed to maintain consistent growth and differentiation properties, which is crucial for reproducibility in research.
For researchers and clinicians alike, the value of these cell lines is evident; they provide a unique opportunity to explore new biological insights and translate laboratory findings into clinical applications. Investing in TMEM11 Gene Knockout Cell Lines enhances experimental capabilities and strengthens research outcomes.
Our company specializes in the development of cutting-edge biological products and is committed to supporting the scientific community with high-quality tools designed for innovative research. Trust in our expertise to provide reliable and transformative products that drive scientific progress.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.